Newsletters
DTN 017: Decentralizing Longevity Research Funding
Plus: A new human genome project, Microsoft buys fusion energy, a battery you can eat, Texas wants to create a gold-backed digital currency, and more.
Newsletters
Plus: A new human genome project, Microsoft buys fusion energy, a battery you can eat, Texas wants to create a gold-backed digital currency, and more.
Conversations
Laurence Ion is a steward at VitaDAO, a community-owned collective funding early-stage longevity research and drug development. He is a longevity advocate, entrepreneur, investor, and a Dealflow Steward in VitaDAO.
Newsletters
Plus: Brain surgery on a fetus, Dorsey's Bitcoin Legal Defense Fund goes to court, scientists rail against Germany's nuclear phaseout disaster, and more.
Newsletters
Plus: Telescopes on the moon, solar sails for interstellar travel, DIY brain-computer interfaces, and more.
Newsletters
Plus: German students prepare for record-setting space shot, open sourcing nuclear physics, robot lawyers, a new Uranium isotope, and more.
Newsletters
Plus: A guy makes ChatGPT the CEO of his company, China inserts tardigrade DNA into human stem cells, and more
Newsletters
Plus: A leaky nuclear reactor, a chatbot suicide, a government crypto conspiracy, artificial cells, and more.
Conversations
Ben Lamm is the cofounder and CEO of the de-extinction company Colossal Biosciences.
Newsletters
Plus: A landmine hunting drone, Japan's geothermal opportunity, successful launch of the world's first 3D printed rocket, DeSantis and Cruz go after CBDCs, and more.
Newsletters
Plus: Neuromarketing, a samurai sword NFT, regenerating bone from antlers, betrothed in a VR Taco Bell, AI searches for ET, and more.
Newsletters
Plus: Playboy in the metaverse, the vertical farming bubble is popping, a vertical solar power tower, $100M for a bat biology startup, and more.
Conversations
Jean-Louis Kindler is the CEO of Ways2H, a leading commercial provider of Waste-to-Hydrogen solutions for mobility and grid applications.